Table of Contents
List of Tables
List of Figures
Natera Inc Company Overview
Natera Inc Company Snapshot
Natera Inc Pipeline Products and Ongoing Clinical Trials Overview
Natera Inc – Pipeline Analysis Overview
Natera Inc – Key Facts
Natera Inc – Major Products and Services
Natera Inc Pipeline Products by Development Stage
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc Pipeline Products Overview
Panorama Non-Invasive Prenatal Expanded Test
Panorama Non-Invasive Prenatal Expanded Test Product Overview
Panorama Non-Invasive Prenatal Expanded Test Clinical Trial
Prospera Kidney Transplant Rejection Test
Prospera Kidney Transplant Rejection Test Product Overview
Prospera Kidney Transplant Rejection Test Clinical Trial
Reproductive Health Test
Reproductive Health Test Product Overview
Signatera – Bladder Cancer
Signatera – Bladder Cancer Product Overview
Signatera – Breast Cancer
Signatera – Breast Cancer Product Overview
Signatera – Breast Cancer Clinical Trial
Signatera – GI Tumors
Signatera – GI Tumors Product Overview
Signatera – Lung Cancer (Opdivo)
Signatera – Lung Cancer (Opdivo) Product Overview
Signatera – Lung Cancer (Opdivo) Clinical Trial
Signatera – Metastatic Non-Small Cell Lung Cancer
Signatera – Metastatic Non-Small Cell Lung Cancer Product Overview
Signatera – Multiple Myeloma
Signatera – Multiple Myeloma Product Overview
Signatera – Multiple Myeloma Clinical Trial
Signatera – Non-Hodgkin’s Lymphoma
Signatera – Non-Hodgkin’s Lymphoma Product Overview
Signatera – Pan-Cancer
Signatera – Pan-Cancer Product Overview
Signatera – Prostate Cancer
Signatera – Prostate Cancer Product Overview
Natera Inc – Key Competitors
Natera Inc – Key Employees
Natera Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Natera Inc, Recent Developments
Jan 20, 2021: Natera files patent infringement suit against Inivata
Dec 18, 2020: U.S. patent office upholds validity of Natera’s early priority date ’592 cfDNA patent
Oct 05, 2020: Court rejects ArcherDX’s motion to dismiss Natera’s patent infringement case
Aug 07, 2020: Natera files additional suit against ArcherDX
Jun 17, 2020: Anju Software welcomes Natera to its PUBSTRAT partner community
May 18, 2020: Natera and Illumina settle patent dispute
Apr 15, 2020: Natera asserts three new oncology patents against ArcherDX
Mar 04, 2020: Natera to showcase leadership in cell-free DNA at CEoT conference
Mar 03, 2020: Natera receives favorable medicare reimbursement pricing for Prospera
Feb 26, 2020: Natera reports fourth quarter and year 2019 financial results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
Natera Inc Pipeline Products and Ongoing Clinical Trials Overview
Natera Inc Pipeline Products by Equipment Type
Natera Inc Pipeline Products by Indication
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc, Key Facts
Natera Inc, Major Products and Services
Natera Inc Number of Pipeline Products by Development Stage
Natera Inc Pipeline Products Summary by Development Stage
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc Ongoing Clinical Trials Summary
Panorama Non-Invasive Prenatal Expanded Test - Product Status
Panorama Non-Invasive Prenatal Expanded Test - Product Description
Panorama Non-Invasive Prenatal Expanded Test - SNP-based Microdeletion and Aneuploidy Registry
Prospera Kidney Transplant Rejection Test - Product Status
Prospera Kidney Transplant Rejection Test - Product Description
Prospera Kidney Transplant Rejection Test - INTERCOMEX DD-cfDNA-HLA-MMDx Study: Comparing the DD-cfDNA Test to MMDx Microarray Test, Central HLA Antibody Test, and Histology
Prospera Kidney Transplant Rejection Test - PEDAL Study: Prospera Test Enhancement by Detecting Background Cell-free DNA Levels
Prospera Kidney Transplant Rejection Test - Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
Prospera Kidney Transplant Rejection Test - The Prospera Kidney Transplant Active Rejection Assessment Registry: ProActive
Reproductive Health Test - Product Status
Reproductive Health Test - Product Description
Signatera - Bladder Cancer - Product Status
Signatera - Bladder Cancer - Product Description
Signatera - Breast Cancer - Product Status
Signatera - Breast Cancer - Product Description
Signatera - Breast Cancer - A Clinical Study To Evaluate the Molecular Response and Minimal Residual Disease (MRD) in Women with Early Stage Breast Cancer
Signatera - Breast Cancer - Investigator-initiated Phase II Study of Pembrolizumab Immunological Response Evaluation
Signatera - GI Tumors - Product Status
Signatera - GI Tumors - Product Description
Signatera - Lung Cancer (Opdivo) - Product Status
Signatera - Lung Cancer (Opdivo) - Product Description
Signatera - Lung Cancer (Opdivo) - Signatera ctDNA Assay as a Potential Biomarker for Opdivo (Nivolumab) in a Prospective Phase 2 Adjuvant Non-Small Cell Lung Cancer Clinical Trial
Signatera - Metastatic Non-Small Cell Lung Cancer - Product Status
Signatera - Metastatic Non-Small Cell Lung Cancer - Product Description
Signatera - Multiple Myeloma - Product Status
Signatera - Multiple Myeloma - Product Description
Signatera - Multiple Myeloma - Investigator-initiated Phase II Study of Pembrolizumab Immunological Response Evaluation
Signatera - Non-Hodgkin's Lymphoma - Product Status
Signatera - Non-Hodgkin's Lymphoma - Product Description
Signatera - Pan-Cancer - Product Status
Signatera - Pan-Cancer - Product Description
Signatera - Prostate Cancer - Product Status
Signatera - Prostate Cancer - Product Description
Natera Inc, Key Employees
Natera Inc, Subsidiaries
Glossary